PAMCX
Price
$98.08
Change
+$0.30 (+0.31%)
Updated
Jan 23 closing price
Net Assets
31.1B
SDSCX
Price
$31.13
Change
+$0.11 (+0.35%)
Updated
Jan 23 closing price
Net Assets
1.3B
Ad is loading...

PAMCX vs SDSCX

Header iconPAMCX vs SDSCX Comparison
Open Charts PAMCX vs SDSCXBanner chart's image
T. Rowe Price Mid-Cap Growth Adv
Price$98.08
Change+$0.30 (+0.31%)
VolumeN/A
Net Assets31.1B
BNY Mellon Sm/Md Cp Gr I
Price$31.13
Change+$0.11 (+0.35%)
VolumeN/A
Net Assets1.3B
PAMCX vs SDSCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PAMCX vs. SDSCX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a Hold and SDSCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 31.1B vs. SDSCX (1.3B). PAMCX (0.00) and SDSCX (0.00) have matching dividends . PAMCX was incepted earlier than SDSCX: PAMCX (25 years) vs SDSCX (37 years). SDSCX is a more actively managed with annual turnover of: 36.02 vs. PAMCX (21.70). SDSCX has a lower initial minimum investment than PAMCX: SDSCX (1000) vs PAMCX (2500). SDSCX annual gain was more profitable for investors over the last year : 19.40 vs. PAMCX (1.83). SDSCX return over 5 years is better than : 17.95 vs. PAMCX (4.09).
PAMCXSDSCXPAMCX / SDSCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years37 years-
Gain YTD4.0667.70853%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets31.1B1.3B2,398%
Annual Yield % from dividends0.000.00-
Returns for 1 year1.8319.409%
Returns for 3 years-0.6310.51-6%
Returns for 5 years4.0917.9523%
Returns for 10 years32.9381.8340%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVCT6.100.39
+6.83%
Nuvectis Pharma
THC134.42-0.01
-0.01%
Tenet Healthcare Corp
TNC86.28-0.72
-0.83%
Tennant Company
TREE43.31-1.18
-2.65%
LendingTree
TOVX1.44-0.07
-4.64%
Theriva Biologics Inc